QIAGEN NV (QGEN)
45.37
-0.29
(-0.64%)
USD |
NYSE |
Dec 11, 15:37
QIAGEN Market Cap: 9.838B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InflaRx NV | 70.46M |
| CDT Equity, Inc. | 2.966M |
| LENZ Therapeutics, Inc. | 767.23M |
| Liminatus Pharma, Inc. | 24.52M |
| Oruka Therapeutics, Inc. | 1.473B |
Market Cap Related Metrics
| PE Ratio | 24.48 |
| PS Ratio | 4.792 |
| PEG Ratio | 0.0682 |
| Price to Book Value | 2.696 |
| Price to Free Cash Flow | 21.00 |
| Price | 45.37 |
| Earnings Yield | 4.09% |
| PEGY Ratio | 0.0676 |
| Operating PE Ratio | 18.23 |
| Normalized PE Ratio | 22.02 |